Uncategorized
Revolution Medicines prices $2B raise as XBI reaches heights not seen since pandemic
Revolution Medicines prices $2B raise as XBI reaches heights not seen since pandemic
Revolution Medicines is capitalizing on its recent clinical trial success, putting together the biotech industry’s largest public raise since the Covid-19 pandemic.
The company priced its stock and debt offering at … Read More